首頁 > 市場調查報告書 > 製藥

婦科治療

市場調查報告書

商品編碼

1604173

全球不孕症藥物市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global Infertility Drugs Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年11月01日 | 出版商:

Value Market Research | 英文 170 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球不孕症藥物市場需求預計將從 2023 年的 42.3 億美元達到近 75.9 億美元的市場規模，2024-2032 年研究期間複合年成長率為 6.72%。

不孕症藥物是一種旨在解決荷爾蒙失衡和阻礙受孕的生殖問題的藥物治療方法。這些藥物旨在刺激排卵、改善精子生成或調節荷爾蒙週期，從而增加成功懷孕的機會。常見的藥物包括排卵促效劑，如克羅米芬檸檬酸鹽和促性腺激素，有助於誘導女性排卵，以及用於男性的睪固酮或荷爾蒙療法等藥物，以增強精子的產生。此外，一些藥物針對特定的生殖疾病或影響生育能力的潛在疾病。透過糾正荷爾蒙缺乏或改善生殖功能，這些藥物在輔助生殖治療中發揮著至關重要的作用。

市場動態

受生活方式因素、高齡和生殖疾病發病率上升的影響，不孕症盛行率不斷上升，是主要的市場促進因素。隨著越來越多的個人和夫婦尋求治療方案，對有效不孕症藥物的需求不斷成長。生殖醫學的技術進步和創新為市場擴張提供了巨大的機會。新型和改進的生育藥物的開發，包括新型荷爾蒙療法和標靶治療，正在提高不孕症治療的有效性和安全性。這些進步使得更個人化的治療計劃和更高的生育治療成功率成為可能。輔助生殖技術（ART）的日益普及也推動了對不孕症藥物的需求。隨著體外受精 (IVF) 等 ART 手術變得越來越普遍，對最佳化治療結果和提高生育成功率的支持性藥物的需求也在不斷成長。此外，生育診所和專門生殖健康中心的擴大為增加藥物使用提供了機會。這些設施提供全面的治療選擇和個人化護理，推動了對各種不孕症藥物的需求。關於不孕不育和現有治療方法的公眾意識活動和教育舉措有助於市場成長。隨著意識的提高，越來越多的人尋求醫療幫助並探索基於藥物的解決方案來應對生育挑戰。然而，與不孕症藥物和治療相關的高成本以及有限的保險範圍可能會抑制市場成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球不孕症藥物市場的各個細分市場進行了包容性評估。不孕症藥物產業的成長和趨勢為這項研究提供了整體方法。

市場區隔

不孕症藥物市場報告的這一部分提供了國家和區域層面細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人群以及即將到來的機會。

按藥物類別

促性腺激素
芳香酶抑制劑
選擇性雌激素受體調節劑 (SERM)
多巴胺激動劑
其他

按配銷通路

醫院藥房
專業及零售藥房
網路藥房

按最終用戶

男士
女性

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲不孕症藥物市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。不孕症藥物市場的主要參與者包括默沙東公司、Ferring BV、Organon Group Of Companies、雅培、諾華公司、拜耳公司、輝瑞公司、Mankind Pharma、梯瓦製藥工業有限公司、賽諾菲。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 9 章：不孕症藥品公司的競爭格局

不孕不育藥物市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 10 章：公司簡介

頂級公司市佔率分析
市場集中度
Merck & Co. Inc.

公司概況
公司收入
產品
最新動態

Ferring BV

公司概況
公司收入
產品
最新動態

Organon Group Of Companies

公司概況
公司收入
產品
最新動態

Abbott

公司概況
公司收入
產品
最新動態

Novartis AG

公司概況
公司收入
產品
最新動態

Bayer AG

公司概況
公司收入
產品
最新動態

Pfizer Inc.

公司概況
公司收入
產品
最新動態

Mankind Pharma

公司概況
公司收入
產品
最新動態

Teva Pharmaceutical Industries Ltd.

公司概況
公司收入
產品
最新動態

Sanofi

公司概況
公司收入
產品
最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR112115478

The global demand for Infertility Drugs Market is presumed to reach the market size of nearly USD 7.59 Billion by 2032 from USD 4.23 Billion in 2023 with a CAGR of 6.72% under the study period 2024-2032.

Infertility drugs are pharmaceutical treatments designed to address hormonal imbalances and reproductive issues that hinder conception. These medications aim to stimulate ovulation, improve sperm production, or regulate hormonal cycles, thereby increasing the chances of successful pregnancy. Common drugs include ovulation stimulants like clomiphene citrate and gonadotropins, which help induce ovulation in women, and medications like testosterone or hormone therapies for men to enhance sperm production. Additionally, some drugs target specific reproductive disorders or underlying conditions affecting fertility. By correcting hormonal deficiencies or improving reproductive function, these drugs play a crucial role in assisted reproductive treatments.

MARKET DYNAMICS

The rising prevalence of infertility, influenced by lifestyle factors, advanced age, and increasing rates of reproductive disorders, is a primary market driver. As more individuals and couples seek treatment options, the demand for effective infertility drugs is growing. Technological advancements and innovations in reproductive medicine present substantial opportunities for market expansion. The development of new and improved fertility drugs, including novel hormone therapies and targeted treatments, is enhancing the efficacy and safety of infertility management. These advancements enable more personalized treatment plans and higher success rates for fertility treatments. The increasing adoption of assisted reproductive technologies (ART) is also driving demand for infertility drugs. As ART procedures such as in vitro fertilization (IVF) become more prevalent, the need for supportive medications that optimize treatment outcomes and enhance fertility success is growing. Moreover, the expansion of fertility clinics and specialized reproductive health centers provides opportunities for increased drug utilization. These facilities offer comprehensive treatment options and personalized care, driving demand for a wide range of infertility medications. Public awareness campaigns and educational initiatives about infertility and available treatments contribute to market growth. As awareness increases, more individuals are seeking medical help and exploring drug-based solutions to address fertility challenges. However, high costs associated with infertility drugs and treatments, along with limited insurance coverage, may restrain market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Infertility Drugs. The growth and trends of Infertility Drugs industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Infertility Drugs market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Drug Class

Gonadotropins
Aromatase Inhibitors
Selective Estrogen Receptor Modulators (SERMs)
Dopamine Agonists
Others

By Distribution Channel

Hospital Pharmacy
Specialty & Retail Pharmacy
Online Pharmacy

By End-user

Men
Women

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Infertility Drugs market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Infertility Drugs market include Merck & Co. Inc., Ferring B.V., Organon Group Of Companies, Abbott, Novartis AG, Bayer AG, Pfizer Inc., Mankind Pharma, Teva Pharmaceutical Industries Ltd., Sanofi. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. INFERTILITY DRUGS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Drug Class
- 3.7.2 Market Attractiveness Analysis By Distribution Channel
- 3.7.3 Market Attractiveness Analysis By End-user
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL INFERTILITY DRUGS MARKET ANALYSIS BY DRUG CLASS

5.1. Overview By Drug Class
5.2. Historical and Forecast Data Analysis By Drug Class
5.3. Gonadotropins Historic and Forecast Sales By Regions
5.4. Aromatase Inhibitors Historic and Forecast Sales By Regions
5.5. Selective Estrogen Receptor Modulators (SERMs) Historic and Forecast Sales By Regions
5.6. Dopamine Agonists Historic and Forecast Sales By Regions
5.7. Others Historic and Forecast Sales By Regions

6. GLOBAL INFERTILITY DRUGS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

6.1. Overview By Distribution Channel
6.2. Historical and Forecast Data Analysis By Distribution Channel
6.3. Hospital Pharmacy Historic and Forecast Sales By Regions
6.4. Specialty & Retail Pharmacy Historic and Forecast Sales By Regions
6.5. Online Pharmacy Historic and Forecast Sales By Regions

7. GLOBAL INFERTILITY DRUGS MARKET ANALYSIS BY END-USER

7.1. Overview By End-user
7.2. Historical and Forecast Data Analysis By End-user
7.3. Men Historic and Forecast Sales By Regions
7.4. Women Historic and Forecast Sales By Regions

8. GLOBAL INFERTILITY DRUGS MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE INFERTILITY DRUGS COMPANIES

9.1. Infertility Drugs Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF INFERTILITY DRUGS INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Merck & Co. Inc.
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. Ferring B.V.
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Organon Group Of Companies
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Abbott
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. Novartis AG
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. Bayer AG
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Pfizer Inc.
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. Mankind Pharma
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. Teva Pharmaceutical Industries Ltd.
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
10.12. Sanofi
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

簡介目錄圖表

LIST OF TABLES

Market Snapshot
Drivers: Impact Analysis
Restraints: Impact Analysis
List of Raw Material
List of Raw Material Manufactures
Analysis By Drug Class (USD MN)
Gonadotropins Market Sales By Geography (USD MN)
Aromatase Inhibitors Market Sales By Geography (USD MN)
Selective Estrogen Receptor Modulators (SERMs) Market Sales By Geography (USD MN)
Dopamine Agonists Market Sales By Geography (USD MN)
Others Market Sales By Geography (USD MN)
Analysis By Distribution Channel (USD MN)
Hospital Pharmacy Market Sales By Geography (USD MN)
Specialty & Retail Pharmacy Market Sales By Geography (USD MN)
Online Pharmacy Market Sales By Geography (USD MN)
Analysis By End-user (USD MN)
Men Market Sales By Geography (USD MN)
Women Market Sales By Geography (USD MN)
Global Infertility Drugs Market Sales By Geography (USD MN)
North America Market Analysis (USD MN)
United States Market Analysis (USD MN)
Canada Market Analysis (USD MN)
Mexico Market Analysis (USD MN)
Europe Market Analysis (USD MN)
Europe Market Estimate By Country (USD MN)
United Kingdom Market Analysis (USD MN)
France Market Analysis (USD MN)
Germany Market Analysis (USD MN)
Italy Market Analysis (USD MN)
Russia Market Analysis (USD MN)
Spain Market Analysis (USD MN)
Rest of Europe Market Analysis (USD MN)
Asia Pacific Market Analysis (USD MN)
China Market Analysis (USD MN)
Japan Market Analysis (USD MN)
India Market Analysis (USD MN)
South Korea Market Analysis (USD MN)
Australia Market Analysis (USD MN)
South East Asia Market Analysis (USD MN)
Rest of Asia Pacific Market Analysis (USD MN)
Latin America Market Analysis (USD MN)
Brazil Market Analysis (USD MN)
Argentina Market Analysis (USD MN)
Peru Market Analysis (USD MN)
Chile Market Analysis (USD MN)
Rest of Latin America Market Analysis (USD MN)
Middle East & Africa Market Analysis (USD MN)
Saudi Arabia Market Analysis (USD MN)
UAE Market Analysis (USD MN)
Israel Market Analysis (USD MN)
South Africa Market Analysis (USD MN)
Rest of Middle East and Africa Market Analysis (USD MN)
Partnership/Collaboration/Agreement
Mergers And Acquisition

LIST OF FIGURES

Research Scope of Infertility Drugs Report
Market Research Process
Market Research Methodology
Global Infertility Drugs Market Size, By Region (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis By Drug Class
Market Attractiveness Analysis By Distribution Channel
Market Attractiveness Analysis By End-user
Market Attractiveness Analysis By Region
Value Chain Analysis
Global Market Analysis By Drug Class (USD MN)
Gonadotropins Market Sales By Geography (USD MN)
Aromatase Inhibitors Market Sales By Geography (USD MN)
Selective Estrogen Receptor Modulators (SERMs) Market Sales By Geography (USD MN)
Dopamine Agonists Market Sales By Geography (USD MN)
Others Market Sales By Geography (USD MN)
Global Market Analysis By Distribution Channel (USD MN)
Hospital Pharmacy Market Sales By Geography (USD MN)
Specialty & Retail Pharmacy Market Sales By Geography (USD MN)
Online Pharmacy Market Sales By Geography (USD MN)
Global Market Analysis By End-user (USD MN)
Men Market Sales By Geography (USD MN)
Women Market Sales By Geography (USD MN)
Global Market Sales (USD MN)
North America Market Sales (USD MN)
Europe Market Sales (USD MN)
Asia Pacific Market Sales (USD MN)
Latin America Market Sales (USD MN)
Middle East & Africa Market Sales (USD MN)
Recent Development in Industry
Top Company Market Share Analysis